Home
About
Technology
Pipeline
Partners
Investors
Careers
News + Resources
- News
- Resource Library
Menu Menu

About jgdm18

This author has not written his bio yet.

Entries by jgdm18

Nothing Found

Sorry, no posts matched your criteria

Recent Posts

Eyenovia’s Presentation at the Ladenburg Thalmann Healthcare Conference Wednesday July 14, 2021 July 14, 2021
Eyenovia highlights Recent Progress in Three Phase 3 Programs, NDA Review Progress and Licensing Agreements Totaling up to $100 Million in Potential Pre-Commercial Revenue June 15, 2021
Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of MicroLine for the Treatment of Presbyopia May 25, 2021

Pipeline and Technology

MydCombi (Mydriasis)
MicroLine (Presbyopia)
MicroPine (Myopia)
Technology

Corporate Address

Eyenovia, Inc.
295 Madison Avenue
Suite 2400
New York, NY 10017
admin@eyenoviabio.com

Copyright © 2021 Eyenovia, Inc. All rights reserved.

Twitter
Facebook
LinkedIn

Contact
Safe Harbor
Privacy Policy
Terms of Use